Ironwood Pharmaceuticals (IRWD) Cash from Discontinued Operations (2010 - 2019)
Ironwood Pharmaceuticals (IRWD) posted Cash from Discontinued Operations of 11364000.0 for Q1 2019, up 191.53% sequentially from 3898000.0 in Q4 2018.
Ironwood Pharmaceuticals (IRWD) Cash from Discontinued Operations (2010 - 2019) Analysis & Trends
Ironwood Pharmaceuticals has reported Cash from Discontinued Operations for 3 years, with the latest figure at 11364000.0 in Q1 2019.
- Quarterly Cash from Discontinued Operations changed N/A year-over-year to 11364000.0 in Q1 2019, while the trailing twelve-month figure through Dec 2019 was 11364000.0 (up 281.73% YoY) and the FY2019 annual result came in at 11364000.0, down 3.76% from the prior year.
- Cash from Discontinued Operations grew to 11364000.0 in Q1 2019 per IRWD's latest filing, from 3898000.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 11364000.0 in Q1 2019 and troughed at 2605000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 706.94 Mn | 627.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 11.36 Mn |
| Mar 31, 2019 | 11.36 Mn |
| Dec 31, 2018 | 3.90 Mn |
| Dec 31, 2018 | 3.90 Mn |
| Sep 30, 2018 | 2.61 Mn |
| Sep 30, 2018 | 2.61 Mn |
| Sep 30, 2010 | -3.53 Mn |
| Sep 30, 2010 | -3.53 Mn |